1. Tacken PJ, Torensma R, Figdor CG. Targeting antigens to dendritic cells in vivo.
Immunobiology, 2006. 211(6-8): 599-608.
2. van Lieshout AW, van der Voort R, le Blanc LM, Roelofs MF,
Schreurs BW, van Riel PL, Adema GJ, Radstake TR. Novel insights in the regulation of CCL18
secretion by monocytes and dendritic cells via cytokines, toll-like
receptors and rheumatoid synovial fluid. BMC
Immunol, 2006. 7: 23.
3. Kramer M, Joosten LA, Figdor CG, Van den Berg WB, Radstake
TRDJ, Adema GJ. Closing in on Toll-like
receptors and NOD-LRR proteins in inflammatori disorders..
Future Rheumatology, 2006. 1(4): 465-79.
4. Jacobs H, Pereira C, Tacken P, de Vries J, Punt C, Adema G,
Figdor C. 2006. Ex-vivo generated DC for clinical trials versus in
vivo targeting to DC: critical issues. In DC in the pathogenesis
and immunity of HIV infection.
5. Barentsz JO, Verdijk P, de Vries IJM, Lesterhuis WJ, Scheenen
TWJ, Boerman OC, Oyen WJG, Adema GJ, van Krieken JHJM, Bulte J,
Punt CJA, Heerschap A, Figdor CG. CMR 2005:
9.07: In vivo MR tracking of magnetically labeled dendritic cells:
first clinical experience.. Contrast Media &
Molecular Imaging, 2006. 1(2): 79.
6. Kramer M, Netea MG, de Jong DJ, Kullberg BJ, Adema GJ. Impaired dendritic cell function in Crohn's
disease patients with NOD2 3020insC mutation. J Leukoc
Biol, 2006. 79(4): 860-6.
7. Grauer O, Poschl P, Lohmeier A, Adema GJ, Bogdahn U. Toll-like receptor triggered dendritic cell
maturation and IL-12 secretion are necessary to overcome T-cell
inhibition by glioma-associated TGF-beta2. J
Neurooncol, 2006. 82(2): 151-61.
8. le Blanc LM, van Lieshout AW, Adema GJ, van Riel PL, Verbeek
MM, Radstake TR. CXCL16 is elevated in the cerebrospinal fluid
versus serum and in inflammatory conditions with suspected and
proved central nervous system involvement. Neurosci
Lett, 2006. 397(1-2): 145-8.
9. Zimmerman AW, Joosten B, Torensma R, Parnes JR, van Leeuwen
FN, Figdor CG. Long-term engagement of CD6 and ALCAM is essential
for T-cell proliferation induced by dendritic cells.
Blood, 2006. 107(8): 3212-20.
10. Gijzen K, Cambi A, Torensma R, Figdor CG. C-type lectins on dendritic cells and their
interaction with pathogen-derived and endogenous
glycoconjugates. Curr Protein Pept Sci, 2006.
7(4): 283-94.
11. Sutmuller RP, Morgan ME, Netea MG, Grauer O, Adema GJ. Toll-like receptors on regulatory T cells:
expanding immune regulation. Trends Immunol,
2006. 27(8): 387-93.
12. van Helden SF, Krooshoop DJ, Broers KC, Raymakers RA, Figdor
CG, van Leeuwen FN. A critical role for prostaglandin E2 in podosome
dissolution and induction of high-speed migration during dendritic
cell maturation. J Immunol, 2006. 177(3):
1567-74.
13. Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW,
Kullberg BJ, Joosten LA, Akira S, Netea MG, Adema GJ. Toll-like receptor 2 controls expansion and
function of regulatory T cells. J Clin Invest,
2006. 116(2): 485-94.
14. Dakappagari N, Maruyama T, Renshaw M, Tacken P, Figdor C,
Torensma R, Wild MA, Wu D, Bowdish K, Kretz-Rommel A. Internalizing antibodies to the C-type lectins,
L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver
antigen to human dendritic cells for the induction of T cell
responses. J Immunol, 2006. 176(1):
426-40.
15. Triantis V, Trancikova DE, Looman MW, Hartgers FC, Janssen
RA, Adema GJ. Identification and characterization of DC-SCRIPT,
a novel dendritic cell-expressed member of the zinc finger family
of transcriptional regulators. J Immunol,
2006. 176(2): 1081-9.
16. Clark K, Langeslag M, van Leeuwen B, Ran L, Ryazanov AG,
Figdor CG, Moolenaar WH, Jalink K, van Leeuwen FN. TRPM7, a novel regulator of actomyosin
contractility and cell adhesion. Embo J, 2006.
25(2): 290-301.
17. Beurden HE, Snoek PA, Hoff JW, Torensma R, Maltha JC,
Kuijpers-Jagtman AM. In vitro migration and adhesion of fibroblasts
from different phases of palatal wound healing. Wound
Repair Regen, 2006. 14(1): 66-71.
18. Benitez-Ribas D, Adema GJ, Winkels G, Klasen IS, Punt CJ,
Figdor CG, de Vries IJ. Plasmacytoid dendritic cells of melanoma patients
present exogenous proteins to CD4+ T cells after Fc gamma
RII-mediated uptake. J Exp Med, 2006. 203(7):
1629-35.
19. den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Toonen
LW, Figdor CG, Ruers TJ, Adema GJ. Synergy between in situ cryoablation and TLR9
stimulation results in a highly effective in vivo dendritic cell
vaccine. Cancer Res, 2006. 66(14):
7285-92.
20. Lesterhuis WJ, de Vries IJ, Schuurhuis DH, Boullart AC,
Jacobs JF, de Boer AJ, Scharenborg NM, Brouwer HM, van de Rakt MW,
Figdor CG, Ruers TJ, Adema GJ, Punt CJ. Vaccination of colorectal cancer patients with
CEA-loaded dendritic cells: antigen-specific T cell responses in
DTH skin tests. Ann Oncol, 2006. 17(6):
974-80.
21. Netea MG, Gow NA, Munro CA, Bates S, Collins C, Ferwerda G,
Hobson RP, Bertram G, Hughes HB, Jansen T, Jacobs L, Buurman ET,
Gijzen K, Williams DL, Torensma R, McKinnon A, MacCallum DM, Odds
FC, Van der Meer JW, Brown AJ, Kullberg BJ. Immune sensing of Candida albicans requires
cooperative recognition of mannans and glucans by lectin and
Toll-like receptors. J Clin Invest, 2006.
116(6): 1642-50.
22. Laverman P, de Vries IJ, Scharenborg NM, de Boer A, Broekema
M, Oyen WJ, Figdor CG, Adema GJ, Boerman OC. Development of 111In-labeled tumor-associated
antigen peptides for monitoring dendritic-cell-based
vaccination. Nucl Med Biol, 2006. 33(4):
453-8.
23. Triantis V, Moulin V, Looman MW, Hartgers FC, Janssen RA,
Adema GJ. Molecular characterization of the murine homologue
of the DC-derived protein DC-SCRIPT. J Leukoc
Biol, 2006. 79(5): 1083-91.
24. Emmer PM, van der Vlag J, Adema GJ, Hilbrands LB. Dendritic cells activated by lipopolysaccharide
after dexamethasone treatment induce donor-specific allograft
hyporesponsiveness. Transplantation, 2006.
81(10): 1451-9.
25. Cambi A, Joosten B, Koopman M, de Lange F, Beeren I,
Torensma R, Fransen JA, Garcia-Parajo M, van Leeuwen FN, Figdor CG.
Organization of the integrin LFA-1 in nanoclusters
regulates its activity. Mol Biol Cell, 2006.
17(10): 4270-81.
26. den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Frielink
C, Toonen LW, Boerman OC, Figdor CG, Ruers TJ, Adema GJ. Efficient loading of dendritic cells following
cryo and radiofrequency ablation in combination with immune
modulation induces anti-tumour immunity. Br J
Cancer, 2006. 95(7): 896-905.